The role of epidermal growth factor in platelet-endothelium interactions

Journal of Physiology and Pharmacology

Volumn 49, Issue 2, 1998, Pages 229-239

  Lukaszyk A ^a   Bodzenta Lukaszyk A ^a   Aksiucik, A ^a   Gabryelewicz, A ^c   Konturek, S J ^b   Bielawiec, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c NONE

Author keywords

Endothelium; Epidermal growth factor; Platelet function

Indexed keywords

BETA THROMBOGLOBULIN; ENDOTHELIN 1; ENDOTHELIN 2; EPIDERMAL GROWTH FACTOR; LEUKOTRIENE C4; PHENTOLAMINE; THROMBOCYTE FACTOR 4; THROMBOXANE B2;

ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BLOOD LEVEL; EXERCISE; HUMAN; MALE; NORMAL HUMAN; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM;

ADULT; ANTIHYPERTENSIVE AGENTS; BETA-THROMBOGLOBULIN; BLOOD PLATELETS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; EPIDERMAL GROWTH FACTOR; EXERCISE; HUMANS; LEUKOTRIENE C4; MALE; PHENTOLAMINE; PLATELET FACTOR 4; THROMBOXANE B2;

EID: 2642646231     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979; 48: 193-216.
2. Marti U, Burwen SJ, Jones AL. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An uptake. Hepatology 1989; 9: 126-138.
3. Mroczkowski B, Reich M. Identification of biologically active epidermal growth factor precursor in human fluids and secretions. Endocrinology 1993; 132: 417-425.
4. Oka Y, Orth DN. Human plasma epidermal growth factor β-urogastrone is associated with blood platelets. J Clin Invest 1983; 72: 249-259.
5. Ben-Ezra J, Sheibani K, Hwang DL, Lev-Ran A. Megakariocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 1990; 137: 755-759.
6. Hwang DL, Latus LJ, Lev-Ran A. Effects of platelet - contained growth factors (PDGF, EGF, IGF-1 and TGF-β) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res 1992; 200: 358-360.
7. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
8. Herndon DN, Nguyen TT, Gilpin DA. Growth factors. Local and systemic. Arch Surg 1993; 128: 1227-1233.
9. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1993; 295: 369-377 (part I), 420-425 (part II).
10. Konradsen L, Nexo E. Epidermal growth factor in plasma, serum and urine before and after prolonged exercise. Reg Pept 1988; 21: 197-203.
11. Christensen NJ, Galbo H, Hansen JF, Hesse B, Richter EA, Trap-Jensen J. Catecholamines and exercise. Diabetes 1979; 28: 58-62.
12. Bodzenta-Łukaszyk A, Łukaszyk A, Aksiucik A, Gabryelewicz A, Konturek SJ. The role of epidermal growth factor in human platelet function. Blood Coagul Fibrinolysis 1997; (submitted for publication).
13. Fortuin NJ. Exercise stress testing. Circulation 1977; 56: 699-712.
14. Blay J, Brown KD. Contradistinctive growth responses of cultured rat intestinal epithelial cells to epidermal growth factor depending on cell population density. J Cell Physiol 1986; 129: 343-346.
15. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987; 56: 881-914.
16. Levine L, Hassid A. Epidermal growth factor stimulates prostaglandin biosynthesis by canine kidney (MDCK) cells. Biochem Biophys Res Commun 1977; 76: 1181-1187.
17. Rigas A, Levine L. Arachidonic acid metabolism by rat liver cells (the C-9 cell line). J Pharmacol Exp Ther 1984; 231: 230-235.
18. Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 1978; 77: 774-788.
19. Ristimaki A, Ylikorkala O, Perheentupa J, Viinikka L. Epidermal growth factor stimulates prostacyclin production by cultured human vascular endothelial cells. Thromb Haemost 1988; 59: 248-250.
20. Ristimaki A. Transforming growth factor α stimulates prostacyclin production by cultured human vascular endothelial cells more potently than epidermal growth factor. Biochem Biophys Res Commun 1989; 160: 1100-1105.
21. Ferguson E, Guest M. Exercise, physical conditioning, blood coagulation and fibrinolysis. Thromb Diath Haemorrh 1974; 31: 63-66.
22. Ikkala E, Myllyla G. Sarajas HS. Haemostatic changes associated with exercise. Nature 1963; 199: 459-461.
23. Warlow CP, Ogston D. Effect of exercise on platelet count, adhesion and aggregation. Acta Haematol 1974; 52: 47-52.
24. Colwell JA. Effects of exercise on platelet function, coagulation and fibrinolysis. Diabetes Metab Rev 1986; 1: 501-512.
25. Bourey RE, Santoro SA. Interactions of exercise, coagulation, platelets and fibrinolysis: a brief review. Med Sci Sports Exerc 1988; 20: 439-446.
26. Taniguchi N, Furui H, Yamauchi K, Sotobata I. Effects of treadmil exercise on platelet functions and blood coagulating activities in healthy men. Jpn Heart J 1984; 25: 167-180.
27. 2 ratios. Thromb Res 1992; 65: 487-493.
28. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kabayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
29. Schrör K. Prostaglandins, other eicosanoids and endothelial cells. Basic Res Cardiol 1985; 80: 502-514.
30. Nexo E, Hansen MR, Konradsen L. Human salivary epidermal growth factor haptocorrin and amylase before and after prolonged exercise. Scand J Clin Lab Invest 1988; 48: 269-273.
31. Kubisz P, Levy-Toledano S, Cronberg S, Pinkhas J, Caen J. Effect of phentolamine, an alpha-receptor blocking agent, on epinephrine, ADP and collagen-induced platelet factor 4 release and platelet aggregation. Rev Eur Etud Clin Biol 1970; 15: 429-434.
32. Bylund DB, Eikenberg DC, Hieble JP et al. IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994; 46: 121-136.
33. Ware JA, Heistad DD. Platelet - endothelium interactions. N Engl J Med 1993; 328: 628-635.
34. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994; 24: Suppl. 3, S16-S26.